GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Pre-Tax Income

Arch Biopartners (TSXV:ARCH) Pre-Tax Income : C$-1.95 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Arch Biopartners's pretax income for the three months ended in Dec. 2023 was C$-0.78 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.95 Mil. Arch Biopartners's pretax margin was %.

During the past 13 years, Arch Biopartners's highest Pretax Margin was -782.35%. The lowest was -2226.60%. And the median was -2207.89%.


Arch Biopartners Pre-Tax Income Historical Data

The historical data trend for Arch Biopartners's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Pre-Tax Income Chart

Arch Biopartners Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.09 -4.63 -1.17 -1.41 -3.33

Arch Biopartners Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.16 -0.96 -0.45 0.24 -0.78

Competitive Comparison of Arch Biopartners's Pre-Tax Income

For the Biotechnology subindustry, Arch Biopartners's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Pre-Tax Income falls into.



Arch Biopartners Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Arch Biopartners's Pretax Income for the fiscal year that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.996+0.012+-0.359+0.017+-0.00099999999999989
=-3.33

Arch Biopartners's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.703+0.009+-0.089+0+-1.1102230246252E-16
=-0.78

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arch Biopartners  (TSXV:ARCH) Pre-Tax Income Explanation

Arch Biopartners's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.783/0
=%

During the past 13 years, Arch Biopartners's highest Pretax Margin was -782.35%. The lowest was -2226.60%. And the median was -2207.89%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arch Biopartners Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Arch Biopartners (TSXV:ARCH) Business Description

Traded in Other Exchanges
N/A
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.